Detalhe da pesquisa
1.
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Ann Rheum Dis
; 82(7): 920-926, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019614
2.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
JAMA
; 326(6): 499-518, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228774
3.
Immune Checkpoint Inhibitor Therapy Toxicities-Reply.
JAMA
; 326(1): 87-88, 2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34228068
4.
Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy.
JAMA
; 325(5): 482-483, 2021 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528524
5.
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.
Clin Pharmacol Ther
; 109(3): 688-696, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210302
6.
Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19.
Clin Pharmacol Ther
; 108(3): 425-427, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488861
7.
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19.
medRxiv
; 2020 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32743594
8.
Socially optimal pandemic drug dosing.
Lancet Glob Health
; 9(8): e1049-e1050, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34139194